Submitted by dcc on Fri, 2017-10-06 14:01 Study Title: A Phase 2 Study of the MEK inhibitor Trametinib (IND #119346, NSC# 763093) in Children with Relapsed or Refractory Juvenile Myelomonocytic LeukemiaCIRB: Pediatric CIRBLead Group: COGStatus: ActiveReview Status: Available to Open
